Translational underpinnings of motivation for alcohol in humans
人类饮酒动机的转化基础
基本信息
- 批准号:10345709
- 负责人:
- 金额:$ 41.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-17 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAlcoholic beverage heavy drinkerAlcoholsAttentionBasic ScienceBehaviorBehavioral SciencesBiological MarkersBlood TestsBlood specimenClinicalClinical SciencesCollectionComputer AssistedCorticotropinData AnalyticsData SetDevelopmentDimensionsDisease ProgressionEmotionalEthanolExecutive DysfunctionGrowthHumanHydrocortisoneImpairmentIndividualInflammationInfusion proceduresInterleukin-10Interleukin-6LaboratoriesLongterm Follow-upMachine LearningMethodologyModelingMotivationNeurobiologyOutcomeOutcome AssessmentParticipantPatient Self-ReportPeripheralPhenotypeProtocols documentationReportingResearchRewardsRoleSamplingScheduleSelf AdministrationSeveritiesSideStagingSystemTNF geneTestingTranslational ResearchTranslationsWorkaddictionalcohol cravingalcohol reinforcementalcohol rewardalcohol seeking behavioralcohol use disorderanalytical methodbiomarker developmentblood-based biomarkerbreath alcohol measurementclinical applicationclinical translationcravingdiscountingdisease classificationdrinkinghypothalamic-pituitary-adrenal axisincentive salienceinnovationinsightintravenous administrationmachine learning modelnegative moodphenomenological modelspre-clinicalpre-clinical researchpreferenceresponsetherapy development
项目摘要
ABSTRACT
Despite significant advances in the understanding of the neurobiology of alcohol use disorder (AUD), there is a
gap in the translation of these insights into clinical applications. Translational research in AUD is facilitated by
the use of experimental manipulations and theoretical constructs that can be studied across species. Towards
advancing translational research in AUD, the PI completed an Exploratory/Developmental Project entitled:
“Modeling alcohol reward and reinforcement in the human laboratory” (R21 AA022752). The objective was to
develop and test a translational task of motivation for alcohol in humans. To do so, we combined alcohol
challenge with progressive ratio self-administration methodologies. Alcohol was administered intravenously
using the Computer-Assisted Self-Infusion of Ethanol (CASE) system. At BrAC = 0.06 g/dl, participants
completed a progressive ratio self-administration task in which they were allowed to work to be infused more
alcohol following a progressive ratio schedule. The alcohol self-administration task captures motivation for
alcohol and mirrors preclinical methodologies, ideal for testing of translational hypotheses. In addition to
developments in the “outcome side” of the modeling approach, the “predictor side” comprised of AUD
phenomenology has progressed towards clinical translation. The Addiction Neuroclinical Assessment (ANA)
proposed to parse AUD phenomenology into three domains, namely incentive salience, negative emotionality,
and executive dysfunction. Our research group has recently provided an independent replication of the ANA
framework in a sample of 1,679 heavy drinkers. Together with the innovation in outcome assessment (i.e.,
progressive ratio self-administration in humans), the ANA framework can inform staging of AUD progression
and as such, motivation for alcohol in humans provides an ideal behavioral science outcome. The proposed
R01 application builds upon the extensive work from our laboratory on the development of a translational task
for drinking motivation in humans. It does so by testing the three dimensions of the ANA for their effects on
alcohol motivation in individuals with AUD.
摘要
尽管在了解酒精使用障碍(AUD)的神经生物学方面取得了重大进展,但仍有
在将这些见解转化为临床应用方面存在差距。澳大利亚的翻译研究通过以下方式得到促进
使用可以跨物种研究的实验操作和理论构造。朝向
为了推进澳元的翻译研究,国际翻译协会完成了一个探索性/发展项目,题为:
《人体实验室酒精奖励与强化模型》(R21 AA022752)。我们的目标是
开发并测试一项人类饮酒动机的翻译任务。为了做到这一点,我们将酒精
挑战渐进式比率自我管理方法。酒精是通过静脉注射的
使用计算机辅助乙醇自我输注(CASE)系统。在brc=0.06g/dl时,参与者
完成了累进比例的自我管理任务,允许他们工作以获得更多
酒精按照递进比例时间表。酒精自我管理任务捕捉到了
酒精和镜像临床前方法学,非常适合测试翻译假说。除了……之外
在建模方法的“结果方面”方面的发展,“预测方面”由澳元组成
现象学已经向临床翻译迈进。成瘾神经临床评估(ANA)
提出将AUD现象学解析为三个领域,即激励显著、消极情绪、
和执行功能障碍。我们的研究小组最近提供了一个独立的ANA复制品
对1,679名酗酒者进行了抽样调查。与成果评估的创新(即,
人类自我给药的进展率),ANA框架可以为AUD进展提供信息
因此,人类饮酒的动机提供了一个理想的行为科学结果。建议数
R01应用程序建立在我们实验室开发翻译任务的广泛工作基础上
对人类饮酒动机的影响。它通过测试ANA的三个维度来测试它们对
AUD患者的酒精动机。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LARA A. RAY其他文献
LARA A. RAY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LARA A. RAY', 18)}}的其他基金
The effects of stress on decision-making in alcohol use disorder: A translational approach
压力对酒精使用障碍决策的影响:转化方法
- 批准号:
10667891 - 财政年份:2023
- 资助金额:
$ 41.93万 - 项目类别:
Integrating findings across stages of medication development for AUD
整合 AUD 药物开发各个阶段的发现
- 批准号:
10353926 - 财政年份:2021
- 资助金额:
$ 41.93万 - 项目类别:
A Novel Human Laboratory Model for Screening Medications for Alcohol Use Disorder
用于筛选酒精使用障碍药物的新型人体实验室模型
- 批准号:
10387543 - 财政年份:2021
- 资助金额:
$ 41.93万 - 项目类别:
A Randomized Controlled Clinical Trial of the Neuroimmune Modulator Ibudilast for the Treatment of Alcohol Use Disorder
神经免疫调节剂异丁司特治疗酒精使用障碍的随机对照临床试验
- 批准号:
10387454 - 财政年份:2021
- 资助金额:
$ 41.93万 - 项目类别:
Integrating findings across stages of medication development for AUD
整合 AUD 药物开发各个阶段的发现
- 批准号:
10491120 - 财政年份:2021
- 资助金额:
$ 41.93万 - 项目类别:
A Novel Human Laboratory Model for Screening Medications for Alcohol Use Disorder
用于筛选酒精使用障碍药物的新型人体实验室模型
- 批准号:
10019310 - 财政年份:2019
- 资助金额:
$ 41.93万 - 项目类别:
A NOVEL HUMAN LABORATORY MODEL FOR SCREENING MEDICATIONS FOR ALCOHOL USE DISORDER
用于筛选酒精使用障碍药物的新型人体实验室模型
- 批准号:
10095672 - 财政年份:2019
- 资助金额:
$ 41.93万 - 项目类别:
A randomized controlled clinical trial of the neuroimmune modulator ibudilast for the treatment of alcohol use disorder
神经免疫调节剂异丁司特治疗酒精使用障碍的随机对照临床试验
- 批准号:
9883692 - 财政年份:2018
- 资助金额:
$ 41.93万 - 项目类别:
Clinical neuroscience of alcoholism: integrating neuroscience and clinical trials
酗酒的临床神经科学:神经科学与临床试验的结合
- 批准号:
10242146 - 财政年份:2018
- 资助金额:
$ 41.93万 - 项目类别:
Clinical neuroscience of alcoholism: integrating neuroscience and clinical trials
酗酒的临床神经科学:神经科学与临床试验的结合
- 批准号:
10481839 - 财政年份:2018
- 资助金额:
$ 41.93万 - 项目类别:














{{item.name}}会员




